Department of Radiology, Sheba Medical Center, Emek Ha-Ella 1 st. Tel Hashomer, 5265601, Ramat Gan, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eur Radiol. 2023 Apr;33(4):2935-2944. doi: 10.1007/s00330-022-09234-z. Epub 2022 Nov 8.
To test the diagnostic performance of breast dynamic contrast-enhanced (DCE) MRI during lactation.
Datasets of 198 lactating patients, including 66 pregnancy-associated breast cancer (PABC) patients and 132 controls, who were scanned by DCE on 1.5-T MRI, were retrospectively evaluated. Six blinded, expert radiologists independently read a single DCE maximal intensity projection (MIP) image for each case and were asked to determine whether malignancy was suspected and the background-parenchymal-enhancement (BPE) grade. Likewise, computer-aided diagnosis CAD MIP images were independently read by the readers. Contrast-to-noise ratio (CNR) analysis was measured and compared among four consecutive acquisitions of DCE subtraction images.
For MIP-DCE images, the readers achieved the following means: sensitivity 93.3%, specificity 80.3%, positive-predictive-value 70.4, negative-predictive-value 96.2, and diagnostic accuracy of 84.6%, with a substantial inter-rater agreement (Kappa = 0.673, p value < 0.001). Most false-positive interpretations were attributed to either the MIP presentation, an underlying benign lesion, or an asymmetric appearance due to prior treatments. CAD's derived diagnostic accuracy was similar (p = 0.41). BPE grades were significantly increased in the healthy controls compared to the PABC cohort (p < 0.001). CNR significantly decreased by 11-13% in each of the four post-contrast images (p < 0.001).
Breast DCE MRI maintains its high efficiency among the lactating population, probably due to a vascular-steal phenomenon, which causes a significant reduction of BPE in cancer cases. Upon validation by prospective, multicenter trials, this study could open up the opportunity for breast MRI to be indicated in the screening and diagnosis of lactating patients, with the aim of facilitating an earlier diagnosis of PABC.
• A single DCE MIP image was sufficient to reach a mean sensitivity of 93.3% and NPV of 96.2%, to stress the high efficiency of breast MRI during lactation. • Reduction in BPE among PABC patients compared to the lactating controls suggests that several factors, including a possible vascular steal phenomenon, may affect cancer patients. • Reduction in CNR along four consecutive post-contrast acquisitions highlights the differences in breast carcinoma and BPE kinetics and explains the sufficient conspicuity on the first subtracted image.
测试哺乳期乳腺动态对比增强(DCE)MRI 的诊断性能。
回顾性分析了 198 例哺乳期患者(包括 66 例妊娠相关性乳腺癌(PABC)患者和 132 例对照)的数据集,这些患者均在 1.5-T MRI 上进行了 DCE 扫描。六位盲法、有经验的放射科医生独立阅读了每位患者的单次 DCE 最大强度投影(MIP)图像,并要求他们判断是否怀疑为恶性肿瘤以及背景实质增强(BPE)分级。同样,读者也独立阅读了计算机辅助诊断(CAD)MIP 图像。在 DCE 减影图像的四个连续采集之间测量并比较了对比噪声比(CNR)分析。
对于 MIP-DCE 图像,读者的平均值如下:敏感性 93.3%,特异性 80.3%,阳性预测值 70.4%,阴性预测值 96.2%,诊断准确率为 84.6%,具有显著的组内一致性(Kappa=0.673,p 值<0.001)。大多数假阳性解释归因于 MIP 呈现、潜在良性病变或由于先前治疗而导致的不对称外观。CAD 获得的诊断准确率相似(p=0.41)。与 PABC 队列相比,健康对照组的 BPE 分级显著增加(p<0.001)。在每个对比后图像中,CNR 均显著降低 11-13%(p<0.001)。
在哺乳期人群中,乳腺 DCE MRI 仍然具有高效性,这可能归因于一种血管盗流现象,该现象导致癌症病例中 BPE 显著减少。通过前瞻性、多中心试验验证后,本研究可能为乳腺 MRI 在哺乳期患者的筛查和诊断中提供机会,目的是促进 PABC 的早期诊断。
单次 DCE MIP 图像足以达到 93.3%的平均敏感性和 96.2%的阴性预测值,强调了哺乳期乳腺 MRI 的高效性。
PABC 患者与哺乳期对照组相比,BPE 减少表明,包括可能的血管盗流现象在内的多种因素可能会影响癌症患者。
在四个连续的对比后采集过程中 CNR 的减少突出了乳腺癌和 BPE 动力学的差异,并解释了第一次减影图像上的充分显著性。